Exhibits
10-K
from 10-K
174 pages
10-K
03/13/24
EX-10.13
from 10-K
41 pages
Exclusive License Agreement Agt. No
03/13/24
EX-10.14
from 10-K
44 pages
Lease Idb 17-19 Drydock Limited Partnership, a Delaware Limited Partnership Landlord and Entrada Therapeutics, Inc., a Delaware Corporation Tenant for the Innovation and Design Building Premises Located on the Fifth (5th) and Sixth (6th) Floors of One Design Center Place Boston, Massachusetts March 16, 2022
03/13/24
EX-10.16
from 10-K
78 pages
Strategic Collaboration and License Agreement Between Vertex Pharmaceuticals Incorporated and Entrada Therapeutics, Inc. December 7, 2022 Strategic Collaboration and License Agreement
03/13/24
EX-10.17
from 10-K
52 pages
Sublicense Agreement Between Vertex Pharmaceuticals Incorporated and Entrada Therapeutics, Inc. December 7, 2022 Sublicense Agreement
03/13/24
EX-21.1
from 10-K
1 page
Subsidiaries of the registrant
03/13/24
EX-23.1
from 10-K
1 page
Consent of expert or counsel
03/13/24
EX-31.1
from 10-K
1 page
Management certification of annual or quarterly disclosure
03/13/24
EX-31.2
from 10-K
1 page
Management certification of annual or quarterly disclosure
03/13/24
EX-32.1
from 10-K
1 page
Management certification of financial report
03/13/24
EX-97.1
from 10-K
4 pages
03/13/24
Graphics & Data Files
GRAPHIC
from 10-K
trda-20231231_g1.jpg
03/13/24
GRAPHIC
from 10-K
trda-20231231_g10.jpg
03/13/24
GRAPHIC
from 10-K
trda-20231231_g11.jpg
03/13/24
GRAPHIC
from 10-K
trda-20231231_g12.jpg
03/13/24
GRAPHIC
from 10-K
trda-20231231_g13.jpg
03/13/24
GRAPHIC
from 10-K
trda-20231231_g14.jpg
03/13/24
GRAPHIC
from 10-K
trda-20231231_g15.jpg
03/13/24
GRAPHIC
from 10-K
trda-20231231_g16.jpg
03/13/24
GRAPHIC
from 10-K
trda-20231231_g17.jpg
03/13/24
GRAPHIC
from 10-K
trda-20231231_g18.jpg
03/13/24
GRAPHIC
from 10-K
trda-20231231_g19.jpg
03/13/24
GRAPHIC
from 10-K
trda-20231231_g2.jpg
03/13/24
GRAPHIC
from 10-K
trda-20231231_g20.jpg
03/13/24
GRAPHIC
from 10-K
trda-20231231_g21.jpg
03/13/24
GRAPHIC
from 10-K
trda-20231231_g22.jpg
03/13/24
GRAPHIC
from 10-K
trda-20231231_g23.jpg
03/13/24
GRAPHIC
from 10-K
trda-20231231_g24.jpg
03/13/24
GRAPHIC
from 10-K
trda-20231231_g25.jpg
03/13/24
GRAPHIC
from 10-K
trda-20231231_g26.jpg
03/13/24
GRAPHIC
from 10-K
trda-20231231_g27.jpg
03/13/24
GRAPHIC
from 10-K
trda-20231231_g28.jpg
03/13/24
GRAPHIC
from 10-K
trda-20231231_g29.jpg
03/13/24
GRAPHIC
from 10-K
trda-20231231_g3.jpg
03/13/24
GRAPHIC
from 10-K
trda-20231231_g30.jpg
03/13/24
GRAPHIC
from 10-K
trda-20231231_g31.jpg
03/13/24
GRAPHIC
from 10-K
trda-20231231_g32.jpg
03/13/24
GRAPHIC
from 10-K
trda-20231231_g33.jpg
03/13/24
GRAPHIC
from 10-K
trda-20231231_g34.jpg
03/13/24
GRAPHIC
from 10-K
trda-20231231_g35.jpg
03/13/24
GRAPHIC
from 10-K
trda-20231231_g36.jpg
03/13/24
GRAPHIC
from 10-K
trda-20231231_g37.jpg
03/13/24
GRAPHIC
from 10-K
trda-20231231_g38.jpg
03/13/24
GRAPHIC
from 10-K
trda-20231231_g4.jpg
03/13/24
GRAPHIC
from 10-K
trda-20231231_g5.jpg
03/13/24
GRAPHIC
from 10-K
trda-20231231_g6.jpg
03/13/24
GRAPHIC
from 10-K
trda-20231231_g7.jpg
03/13/24
GRAPHIC
from 10-K
trda-20231231_g8.jpg
03/13/24
GRAPHIC
from 10-K
trda-20231231_g9.jpg
03/13/24
